Related Experiment Videos
[Hemophagocytic syndromes and primary immunodeficiencies]
1Unité d'hématologie et oncologie pédiatrique, hôpital NORD, CHU de Saint-Etienne, 42055 Saint-Etienne, France. j.louis.stephan@chu-st-etienne.fr
Summary
Lymphohistiocytic activation syndromes involve T cell and macrophage overactivity, often mimicking sepsis. Identifying underlying or inherited conditions is crucial for effective treatment, including bone marrow transplantation for genetic forms.
Area of Science:
- Immunology
- Hematology
- Genetics
Context:
- Lymphohistiocytic activation syndromes (LAS) are severe immune responses.
- LAS often presents with sepsis-like symptoms.
- Underlying conditions like hemopathy, autoimmune diseases, or infections frequently predispose patients to LAS.
Purpose:
- To define lymphohistiocytic activation syndromes.
- To highlight the clinical presentation and diagnostic considerations for LAS.
- To outline treatment strategies for LAS, including curative options for genetic forms.
Summary:
- LAS are characterized by uncontrolled T cell and macrophage activation, typically in response to infection.
- Clinical manifestations can be severe, resembling sepsis, and often occur in patients with pre-existing conditions.
- In rare cases without apparent risk factors, inherited disorders like familial lymphohistiocytosis should be investigated.
- Treatment involves immunosuppression, with bone marrow transplantation offering a cure for genetic LAS.
Impact:
- Improved understanding of LAS pathogenesis and clinical recognition.
- Enhanced diagnostic approaches for identifying underlying genetic predispositions.
- Guidance on therapeutic interventions, emphasizing the potential of bone marrow transplantation for cure.